OPKO Health (OPK) Tops Q2 EPS by 7c ; Offers Guidance

OPKO Health (NASDAQ: OPK) reported Q2 EPS of ($0.01), $0.07 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $163.5 million versus the consensus estimate of $131.03 million.

Outlook:-

Q3 2026 revenue between $131 million to $142 million vs consensus $134.7 million.
FY 2026 revenue between $560million to $585 million vs consensus $536.9 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.

You May Also Be Interested In

• Northland Upgrades Evolution Petroleum (EPM) to Outperform 'on Pullback & Attractive Royalty Acquisition'
• Dollar Tree (DLTR) PT Raised to $145 at Raymond James
• SentinelOne, Inc. (S) Tops Q2 EPS by 1c; offers guidance